Sartorius Stedim Biotech SASartorius Stedim Biotech SASartorius Stedim Biotech SA

Sartorius Stedim Biotech SA

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪19.31 B‬EUR
2.30EUR
‪175.10 M‬EUR
‪2.78 B‬EUR
‪25.65 M‬
Beta (1Y)
1.45
Employees (FY)
‪9.9 K‬
Change (1Y)
−761 −7.14%
Revenue / Employee (1Y)
‪280.78 K‬EUR
Net income / Employee (1Y)
‪17.69 K‬EUR

About Sartorius Stedim Biotech SA


CEO
René Fáber
Headquarters
Aubagne
Founded
1978
ISIN
FR0013154002
FIGI
BBG00X8QLNM3
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.

Check out other big names from the same industry as DIM.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
VEA
Vanguard FTSE Developed Markets ETF
Weight
0.02%
Market value
‪52.31 M‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
0.03%
Market value
‪45.40 M‬
USD
EFA
iShares MSCI EAFE ETF
Weight
0.03%
Market value
‪22.90 M‬
USD
VGK
Vanguard FTSE Europe ETF
Weight
0.04%
Market value
‪13.85 M‬
USD
SCHF
Schwab International Equity ETF
Weight
0.03%
Market value
‪13.61 M‬
USD
XT
iShares Future Exponential Technologies ETF
Weight
0.26%
Market value
‪9.83 M‬
USD
IXUS
iShares Core MSCI Total International Stock ETF
Weight
0.02%
Market value
‪9.27 M‬
USD
CSEMU.EUR
iShares Core MSCI EMU UCITS ETF
Weight
0.10%
Market value
‪8.24 M‬
USD
CEUU
iShares Core MSCI EMU UCITS ETF AccumHedged USD
Weight
0.10%
Market value
‪8.24 M‬
USD
CEUG
iShares Core MSCI EMU UCITS ETF
Weight
0.10%
Market value
‪8.24 M‬
USD
EZU
iShares MSCI Eurozone ETF
Weight
0.10%
Market value
‪8.04 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of DIM is 197.50 EUR — it has decreased by −0.38% in the past 24 hours. Watch Sartorius Stedim Biotech SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange Sartorius Stedim Biotech SA stocks are traded under the ticker DIM.
DIM stock has risen by 15.16% compared to the previous week, the month change is a 13.83% rise, over the last year Sartorius Stedim Biotech SA has showed a 7.60% increase.
We've gathered analysts' opinions on Sartorius Stedim Biotech SA future price: according to them, DIM price has a max estimate of 251.00 EUR and a min estimate of 210.00 EUR. Watch DIM chart and read a more detailed Sartorius Stedim Biotech SA stock forecast: see what analysts think of Sartorius Stedim Biotech SA and suggest that you do with its stocks.
DIM reached its all-time high on Sep 10, 2021 with the price of 548.20 EUR, and its all-time low was 144.40 EUR and was reached on Jul 22, 2024. View more price dynamics on DIM chart.
See other stocks reaching their highest and lowest prices.
DIM stock is 0.69% volatile and has beta coefficient of 1.45. Track Sartorius Stedim Biotech SA stock price on the chart and check out the list of the most volatile stocks — is Sartorius Stedim Biotech SA there?
Today Sartorius Stedim Biotech SA has the market capitalization of ‪19.30 B‬, it has increased by 15.29% over the last week.
Yes, you can track Sartorius Stedim Biotech SA financials in yearly and quarterly reports right on TradingView.
Sartorius Stedim Biotech SA is going to release the next earnings report on Oct 16, 2025. Keep track of upcoming events with our Earnings Calendar.
DIM earnings for the last quarter are 1.22 EUR per share, whereas the estimation was 1.04 EUR resulting in a 17.50% surprise. The estimated earnings for the next quarter are 0.98 EUR per share. See more details about Sartorius Stedim Biotech SA earnings.
Sartorius Stedim Biotech SA revenue for the last quarter amounts to ‪884.30 M‬ EUR, despite the estimated figure of ‪735.83 M‬ EUR. In the next quarter, revenue is expected to reach ‪696.97 M‬ EUR.
DIM net income for the last quarter is ‪68.60 M‬ EUR, while the quarter before that showed ‪85.60 M‬ EUR of net income which accounts for −19.86% change. Track more Sartorius Stedim Biotech SA financial stats to get the full picture.
Yes, DIM dividends are paid annually. The last dividend per share was 0.69 EUR. As of today, Dividend Yield (TTM)% is 0.35%. Tracking Sartorius Stedim Biotech SA dividends might help you take more informed decisions.
Sartorius Stedim Biotech SA dividend yield was 0.37% in 2024, and payout ratio reached 38.14%. The year before the numbers were 0.29% and 20.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 8, 2025, the company has ‪9.9 K‬ employees. See our rating of the largest employees — is Sartorius Stedim Biotech SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sartorius Stedim Biotech SA EBITDA is ‪795.90 M‬ EUR, and current EBITDA margin is 25.95%. See more stats in Sartorius Stedim Biotech SA financial statements.
Like other stocks, DIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sartorius Stedim Biotech SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sartorius Stedim Biotech SA technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sartorius Stedim Biotech SA stock shows the neutral signal. See more of Sartorius Stedim Biotech SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.